LeMaitre Vascular Sees Q4 GAAP EPS $0.64-$0.69 vs $0.63 Est; Sees Sales $61.800M-$63.800M vs $64.324M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
LeMaitre Vascular (NASDAQ:LMAT) is looking for Q4 GAAP EPS of $0.64-$0.69 vs $0.63 analyst estimate. sees sales of $61.800 million-$63.800 million vs $64.324 million analyst estimate.
LeMaitre Vascular (NASDAQ:LMAT) is looking for Q4 GAAP EPS of $0.64-$0.69 vs $0.63 analyst estimate. sees sales of $61.800 million-$63.800 million vs $64.324 million analyst estimate.